Evidence map›Paper›PMID 41787267›Full record

ArticleBMC microbiology2026

Tuberculosis transmission and resistance among Ukrainian migrants and its impact on multidrug-resistant tuberculosis dynamics in high-influx host countries.

Matúš Dohál, Olha Konstantynovska, Michaela Hromádková, Marek Štrba, Karolína Doležalová, Jiří Wallenfels, Igor Porvazník, Simona Mäsiarová, Michaela Krivošová, Erik Michael Rasmussen and 8 more

Abstract read
In one paragraph

Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Matúš DohálBiomedical Centre Martin, Jessenius Faculty of Medicine in Martin, Comenius University, Malá Hora 4A, 03601, Bratislava, Slovakia. matus.dohal@uniba.sk.
Olha KonstantynovskaDepartment of Infectious Diseases and Clinical Immunology, V.N. Karazin Kharkiv National University, Kharkiv, Ukraine.
Michaela HromádkováNational Institute of Public Health, Šrobárova 48, 10000, Prague, Czech Republic.
Marek ŠtrbaDepartment of Pharmacology, Jessenius Faculty of Medicine in Martin, Comenius University, Bratislava, Slovakia.
Karolína DoležalováDepartment of Paediatrics of the First Faculty of Medicine, Charles University, Thomayer University Hospital, Prague, Czech Republic.
Jiří WallenfelsUniversity Hospital Bulovka, Prague, Czech Republic.
Igor PorvazníkNational Institute of Tuberculosis Lung Diseases and Thoracic Surgery, Vyšné Hágy, Vysoké Tatry, Slovakia.
Simona MäsiarováDepartment of Pharmacology, Jessenius Faculty of Medicine in Martin, Comenius University, Bratislava, Slovakia.
Michaela KrivošováBiomedical Centre Martin, Jessenius Faculty of Medicine in Martin, Comenius University, Malá Hora 4A, 03601, Bratislava, Slovakia.
Erik Michael RasmussenInternational Reference Laboratory of Mycobacteriology, Statens Serum Institut, Copenhagen, Denmark.
Peter KunčClinic of Pediatric Respiratory Diseases and Tuberculosis, National Institute of Pediatric Tuberculosis and Respiratory Diseases, Dolny Smokovec, Jessenius Faculty of Medicine in Martin, Comenius University, Bratislava, Slovakia.
Jarmila HnilicováDepartment of Genetics and Microbiology, Faculty of Science, Charles University, Prague, Czech Republic.
Ivan SolovičNational Institute of Tuberculosis Lung Diseases and Thoracic Surgery, Vyšné Hágy, Vysoké Tatry, Slovakia.
Juraj MokrýDepartment of Pharmacology, Jessenius Faculty of Medicine in Martin, Comenius University, Bratislava, Slovakia.
Ivan BarilarMolecular and Experimental Mycobacteriology, Research Center Borstel, Borstel, 16, Germany.
Stefan NiemannMolecular and Experimental Mycobacteriology, Research Center Borstel, Borstel, 16, Germany.
Margo Diricks *Molecular and Experimental Mycobacteriology, Research Center Borstel, Borstel, 16, Germany.
Věra Dvořáková *National Institute of Public Health, Šrobárova 48, 10000, Prague, Czech Republic. vera.dvorakova@szu.cz.

Funding

Agentúra na Podporu Výskumu a Vývoja 18-0084European Union within the Slovakia Programme ITMS21+: 401101C648NIPH 75010330Vedecká Grantová Agentúra MŠVVaŠ SR a SAV 1/0049/25Vedecká Grantová Agentúra MŠVVaŠ SR a SAV 1/0093/22
6 · The paper itself

Abstract

backgroundThe war in Ukraine triggered unprecedented migration into Central Europe, raising concerns regarding tuberculosis (TB) spread.

methodsWe conducted a molecular-epidemiological study including all Ukrainian migrants with culture-confirmed TB in Slovakia and the Czech Republic between September 2021 and December 2024 (n = 229), together with all other multidrug-resistant (MDR) TB cases reported in these countries between 2023 and 2024 (n = 28). Whole-genome sequencing (WGS) was performed on cultured Mycobacterium tuberculosis complex (MTBC) isolates, and the resulting data were used for phylogenetic reconstruction, lineage classification, genomic resistance prediction, and cluster analysis.

findingsSince the war began in 2022, the share of TB cases from Ukrainian migrants in the Czech Republic rose significantly (P < 0.001), along with an evident increase in total MDR-TB cases. Out of 199 MTBC strains from Ukrainian migrants with good-quality WGS data, 129 (64.8%) were predicted to be susceptible, 25 MDR (12.6%), 8 pre-extensively drug-resistant (pre-XDR; 4%), and 37 (18.6%) had other resistance patterns including bedaquiline/clofazimine monoresistance. Among MDR/pre-XDR strains (n = 59) lineage 2 predominated (63.5%), mainly belonging to the Central Asia clades (45.0%) and the Europe/Russian W148 outbreak clone (52.9%), followed by lineage 4 (28.9%). Cluster analysis (5 allele threshold) identified 10 MDR/pre-XDR TB clusters, each with two isolates. Only one of those clusters included a Ukrainian migrant and non-Ukrainian patient from the host country.

conclusionMigration increased both, the TB and MDR-TB burden especially in the Czech Republic. Transmission of imported MTBC strains from migrants to host populations appears to be limited, but needs to be closely monitered prospectively.

Indexed as

Mycobacterium tuberculosisTransients and MigrantsTuberculosis, Multidrug-ResistantAntitubercular AgentsCzech RepublicDrug Resistance, Multiple, BacterialEastern European PeopleHumansMolecular EpidemiologyPhylogenySlovakiaUkraineWhole Genome SequencingAntitubercular AgentsBeijingepidemiologymigrationmultidrug-resistant tuberculosistransmission

Identifiers

PMID41787267
PMCPMC13072503

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.